Post-acute sequelae of COVID-19: A metabolic perspective

PE Scherer, JP Kirwan, CJ Rosen - Elife, 2022 - elifesciences.org
The SARS-CoV-2 pandemic continues to rage around the world. At the same time, despite
strong public health measures and high vaccination rates in some countries, a post-COVID …

[HTML][HTML] COVID-19 outcomes in patients undergoing B cell depletion therapy and those with humoral immunodeficiency states: a scoping review

JM Jones, AJ Faruqi, JK Sullivan… - Pathogens and …, 2021 - ncbi.nlm.nih.gov
Background: The role of humoral immunity has been well established in reducing infection
risk and facilitating viral clearance in patients with COVID-19. However, the relationship …

SARS-CoV-2-specific immune response in COVID-19 convalescent individuals

Y Pan, X Jiang, L Yang, L Chen, X Zeng, G Liu… - Signal transduction and …, 2021 - nature.com
We collected blood from coronavirus disease 2019 (COVID-19) convalescent individuals
and investigated SARS-CoV-2-specific humoral and cellular immunity in these discharged …

NSP4 and ORF9b of SARS-CoV-2 induce pro-inflammatory mitochondrial DNA release in inner membrane-derived vesicles

MI Faizan, R Chaudhuri, S Sagar, S Albogami… - Cells, 2022 - mdpi.com
Circulating cell-free mitochondrial DNA (cf-mtDNA) has been found in the plasma of
severely ill COVID-19 patients and is now known as a strong predictor of mortality. However …

[HTML][HTML] Research progress of traditional Chinese medicine against COVID-19

W Ren, P Liang, Y Ma, Q Sun, Q Pu, L Dong… - Biomedicine & …, 2021 - Elsevier
Background Currently, the number of confirmed cases and deaths of COVID-19 worldwide
continues to rise, receiving great concern from the international community. However, there …

COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: potential targets and challenges

A Pourgholaminejad… - Scandinavian Journal …, 2022 - Wiley Online Library
The role of the immune system against coronavirus disease 2019 (COVID‐19) is unknown in
many aspects, and the protective or pathologic mechanisms of the immune response are …

Immune-mediated inflammatory responses of alveolar epithelial cells: Implications for COVID-19 lung pathology

A Barilli, R Visigalli, F Ferrari, MG Bianchi, V Dall'Asta… - Biomedicines, 2022 - mdpi.com
Background. Clinical and experimental evidence point to a dysregulated immune response
caused by SARS-CoV-2 as the primary mechanism of lung disease in COVID-19. However …

[HTML][HTML] Development and validation of a predictive model for severe COVID-19: a case-control study in China

Z Meng, M Wang, Z Zhao, Y Zhou, Y Wu, S Guo… - Frontiers in …, 2021 - frontiersin.org
Background: Comprehensively understanding and early predicting the risk of progression to
severe COVID-19 can facilitate personalized diagnosis and treatment options, optimizing …

[HTML][HTML] Деплеция В-клеток при иммуновоспалительных ревматических заболеваниях и коронавирусная болезнь 2019 (COVID-19)

ЕЛ Насонов, АС Авдеева - Научно-практическая ревматология, 2021 - cyberleninka.ru
У пациентов с иммуновоспалительными (аутоиммунными) ревматическими
заболеваниями (ИВРЗ) существует ряд факторов (пожилой возраст …

Reliability of predictive models to support early decision making in the emergency department for patients with confirmed diagnosis of COVID-19: the Pescara Covid …

E Polilli, A Frattari, JE Esposito, M D'Amato… - BMC health services …, 2022 - Springer
Background The hospital management of patients diagnosed with COVID-19 can be
hampered by heterogeneous characteristics at entry into the emergency department. We …